Sei Investments CO Abb Vie Inc. Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

A detailed history of Sei Investments CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Sei Investments CO holds 435,557 shares of ABBV stock, worth $74.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

435,557

Previous 465,038 6.34%

Holding current value

$74.7 Million

Previous $72.1 Million 10.06%

% of portfolio

0.12%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$159.82 - $182.1 $4.71 Million - $5.37 Million	-29,481 Reduced 6.34%	435,557 $79.3 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $3.45 Million - $3.88 Million	25,042 Added 5.69%	465,038 $72.1 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.62 Million - $1.87 Million	12,096 Added 2.83%	439,996 $65.6 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $6.36 Million - $7.91 Million	-47,989 Reduced 10.08%	427,900 $57.7 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $2.9 Million - $3.34 Million	20,047 Added 4.4%	475,889 $75.8 Million

Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $3.05 Million - $3.66 Million	-22,070 Reduced 4.62%	455,842 $73.7 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $6.7 Million - $7.69 Million	-49,953 Reduced 9.46%	477,912 $64.1 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $5.5 Million - $6.99 Million	39,977 Added 8.19%	527,865 $80.9 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $4.08 Million - $5.06 Million	-30,915 Reduced 5.96%	487,888 $79.1 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $2.49 Million - $3.15 Million	23,157 Added 4.67%	518,803 $70.2 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $23.2 Million - $26.4 Million	-218,491 Reduced 30.6%	495,646 $53.5 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $26.6 Million - $29.6 Million	252,807 Added 54.8%	714,137 $80.4 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $904,332 - $995,560	8,840 Added 1.95%	461,330 $49.9 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $1.26 Million - $1.71 Million	-15,715 Reduced 3.36%	452,490 $48.5 Million
Q3 2020 Dec 04, 2020	SELL	$85.91 - $100.83 $1.51 Million - $1.77 Million	-17,579 Reduced 3.62%	468,205 $41.1 Million
Q3 2020 Nov 06, 2020	SELL	$85.91 - $100.83 $8.17 Million - $9.59 Million	-95,073 Reduced 16.37%	485,784 $42.6 Million
Q2 2020 Aug 17, 2020	SELL	$73.37 - $98.18 $1.92 Million - $2.57 Million	-26,184 Reduced 4.31%	580,857 $57 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $5.9 Million - $7.9 Million	80,466 Added 15.28%	607,041 $54.6 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $3.63 Million - $5.51 Million	-56,309 Reduced 9.66%	526,575 $40.2 Million
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $16.3 Million - $20.4 Million	226,098 Added 63.37%	582,884 $51.7 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $11.7 Million - $14 Million	185,333 Added 108.1%	356,786 $27.1 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $1.01 Million - $1.3 Million	-15,437 Reduced 8.26%	171,453 $12.5 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $11.2 Million - $13.2 Million	-145,656 Reduced 43.8%	186,890 $15.1 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $2.41 Million - $2.98 Million	30,995 Added 10.28%	332,546 $31.2 Million
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $16.3 Million - $18.1 Million	-183,082 Reduced 37.78%	301,551 $28.5 Million
Q2 2018 Aug 03, 2018	BUY	$89.78 - $106.23 $2.06 Million - $2.44 Million	22,949 Added 4.97%	484,633 $44.9 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $4.2 Million - $5.63 Million	-45,654 Reduced 9.0%	461,684 $43.7 Million
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $13.1 Million - $14.4 Million	146,386 Added 40.56%	507,338 $49.1 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $25.2 Million - $32.2 Million	360,952	360,952 $32.1 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Abb Vie Inc. Transaction History